Global Biotech Breakthroughs

Qyuns Therapeutics

Market Cap: HK$4.9b

A clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.

CARsgen Therapeutics Holdings

Market Cap: HK$9.1b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$109.4b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Madrigal Pharmaceuticals

Market Cap: US$12.7b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Arcutis Biotherapeutics

Market Cap: US$3.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Akeso

Market Cap: HK$118.1b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Marker Therapeutics

Market Cap: US$36.5m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

SanBio

Market Cap: JP¥126.4b

Engages in the development, production, and sale of regenerative cell medicines for the central nervous system.

Cutia Therapeutics

Market Cap: HK$1.9b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥25.7b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

Mesoblast

Market Cap: AU$3.8b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Guard Therapeutics International

Market Cap: SEK 31.0m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Legend Biotech

Market Cap: US$4.2b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

RenovoRx

Market Cap: US$37.4m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

Lineage Cell Therapeutics

Market Cap: US$412.0m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

Achieve Life Sciences

Market Cap: US$265.6m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

ARS Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Soleno Therapeutics

Market Cap: US$2.5b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥29.3b

A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.

Xspray Pharma

Market Cap: SEK 1.3b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Initiator Pharma

Market Cap: SEK 208.8m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Ascelia Pharma

Market Cap: SEK 402.8m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Valneva

Market Cap: €721.1m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Capricor Therapeutics

Market Cap: US$1.4b

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Aldeyra Therapeutics

Market Cap: US$250.3m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Pelthos Therapeutics

Market Cap: US$86.4m

A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.

Viridian Therapeutics

Market Cap: US$2.9b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Syndax Pharmaceuticals

Market Cap: US$1.8b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

AC Immune

Market Cap: US$339.4m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

AprilBioLtd

Market Cap: ₩1.3t

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

Aelis Farma

Market Cap: €16.0m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

Oxford Biomedica

Market Cap: UK£905.2m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Lipigon Pharmaceuticals

Market Cap: SEK 8.8m

Develops drugs for lipid related diseases in Sweden.

Citius Oncology

Market Cap: US$97.5m

Focuses on the development and commercialization of innovative targeted oncology therapies.

Precigen

Market Cap: US$1.7b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Longeveron

Market Cap: US$13.2m

A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.